Venture Capital

VENTURE CAPITAL PORTFOLIO


Select examples of Weiner Ventures' venture capital investments:

Our investments in manufacturers of LED lighting solutions help accelerate best-in-class launches as well as enhance R&D capabilities. These companies offer businesses and consumers comprehensive, cutting-edge products designed to replace conventional light sources.

LIGHTING

This developer and operator of an extensive fiber optic cable network provides highly efficient internet services worldwide. Continued expansion of affordable and extremely high-capacity broadband data exchange supports a wide variety of global communications for businesses and consumers.

FIBER OPTICS

Media and entertainment investments include online publishing and video platforms to improve distribution of digital content, as well as investments in targeted advertising and customer engagement.

MEDIA & ENTERTAINMENT

Discovering new medicines to treat cancer, this company has developed an innovative platform of technologies and oncology R&D expertise. They push boundaries and overcome biological barriers that limit the effectiveness of many cancer medicines.

CANCER MEDICINES

Developing small molecule drugs that activate progenitor cells in the body, diseases are modified and healthy tissues are restored without genetic engineering. Applications include skin, muscle, hearing, and intestinal disorders.

DISEASE MODIFICATION

A leading-edge technology preserves and transports organs that continue to function outside the body, enabling physicians to deliver more life-saving transplants to more critically-ill patients.

ORGAN PRESERVATION

A clinical stage biopharmaceutical company develops therapies and vaccines that regulate immune responses to prevent and treat diseases. Funding research of synthetic vaccines positions the company to rapidly advance its immune tolerance treatment pipeline.

IMMUNE TOLERANCE VACCINES

To deliver optimal cancer treatment strategies tailored to each patient, this genomic testing firm analyzes hundreds of cancer genes for abnormalities associated with patients’ variable responses to cancer drugs, thereby helping oncologists make informed decisions.

GENE THERAPIES

The rapidly expanding availability of electronic data provides opportunity for building the next major wave of innovative healthcare technology and services companies.

DIGITAL HEALTHCARE